KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Goodwill (2019 - 2025)

Biolife Solutions (BLFS) has disclosed Goodwill for 6 consecutive years, with $208.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Goodwill changed N/A to $208.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $208.6 million, a N/A change, with the full-year FY2025 number at $208.6 million, changed N/A from a year prior.
  • Goodwill was $208.6 million for Q4 2025 at Biolife Solutions, down from $224.7 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $224.7 million in Q1 2022 to a low of $58.4 million in Q1 2021.
  • A 4-year average of $193.2 million and a median of $224.7 million in 2022 define the central range for Goodwill.
  • Biggest YoY gain for Goodwill was 568.35% in 2021; the steepest drop was 0.0% in 2021.
  • Biolife Solutions' Goodwill stood at $58.4 million in 2021, then skyrocketed by 284.51% to $224.7 million in 2022, then changed by 0.0% to $224.7 million in 2023, then decreased by 7.19% to $208.6 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Goodwill are $208.6 million (Q4 2025), $224.7 million (Q3 2023), and $224.7 million (Q2 2023).